These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines. Ferguson JA; Reeves WC; Hardy JL Am J Vet Res; 1977 Apr; 38(4):425-30. PubMed ID: 851275 [TBL] [Abstract][Full Text] [Related]
11. Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta). Stephen EL; Sammons ML; Pannier WL; Baron S; Spertzel RO; Levy HB J Infect Dis; 1977 Jul; 136(1):122-6. PubMed ID: 407312 [TBL] [Abstract][Full Text] [Related]
12. Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84). Edelman R; Ascher MS; Oster CN; Ramsburg HH; Cole FE; Eddy GA J Infect Dis; 1979 Nov; 140(5):708-15. PubMed ID: 528788 [TBL] [Abstract][Full Text] [Related]
13. Venezuelan equine encephalomyelitis vaccine (strain TC-83): a field study. Baker EF; Sasso DR; Maness K; Prichard WD; Parker RL Am J Vet Res; 1978 Oct; 39(10):1627-31. PubMed ID: 717877 [TBL] [Abstract][Full Text] [Related]
14. Glucan-induced enhancement of host resistance to selected infectious diseases. Reynolds JA; Kastello MD; Harrington DG; Crabbs CL; Peters CJ; Jemski JV; Scott GH; Di Luzio NR Infect Immun; 1980 Oct; 30(1):51-7. PubMed ID: 7439978 [TBL] [Abstract][Full Text] [Related]
15. A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis. Vanderwagen LC; Pearson JL; Franti CE; Tamm EL; Riemann HP; Behymer DE Am J Vet Res; 1975 Nov; 36(11):1567-71. PubMed ID: 1190598 [TBL] [Abstract][Full Text] [Related]
16. Studies of glucose metabolism in rhesus monkeys after Venezuelan equine encephalitis virus infection. Bowen GS; Rayfield EJ; Monath TP; Kemp GE J Med Virol; 1980; 6(3):227-34. PubMed ID: 7014785 [TBL] [Abstract][Full Text] [Related]
17. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. Burke DS; Ramsburg HH; Edelman R J Infect Dis; 1977 Sep; 136(3):354-9. PubMed ID: 903673 [TBL] [Abstract][Full Text] [Related]
18. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates. Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359 [TBL] [Abstract][Full Text] [Related]
19. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice. Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206 [TBL] [Abstract][Full Text] [Related]
20. Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83). Ferguson JA; Reeves WC; Milby MM; Hardy JL Am J Vet Res; 1978 Mar; 39(3):371-6. PubMed ID: 637386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]